Nantahala Capital Management »

Nektar Therapeutics shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.1M 4.1M 1.24
2024-03-31 $2.3M 2.5M 0.93

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Eli Lilly & Co. Put Option (LLY)
Eli Lilly & Co. Put Option (LLY)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Spdr Ser Tr S&p Biotech (XBI)
Spdr Ser Tr S&p Biotech (XBI)
Peloton Interactive Cl A Com (PTON)
Peloton Interactive Cl A Com (PTON)
Grand Canyon Education Put Option (LOPE)
Grand Canyon Education Put Option (LOPE)
Imax Corp Cad (IMAX)

View all positions for Nantahala Capital Management

Top funds holding Nektar Therapeutics

Deep Track Capital
BlackRock
Vanguard Group
Samlyn Capital
Eventide Asset Management
Citadel Advisors
PRIMECAP Management Company
Acadian Asset Management
Millennium Management
Geode Capital Management
Nantahala Capital Management
TCG Crossover Management
Renaissance Technologies
State Street Corporation
Jacobs Levy Equity Management

View all funds holding Nektar Therapeutics